Pediatric psoriasis-associated comorbidities: beyond metabolic syndrome

Maria G Buethe1, Mira Choi1,2, Nicola Natsis1,2

  • 1Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, CA, USA.

Insights

Pediatric psoriasis, a chronic skin condition, is linked to various health issues beyond metabolic syndrome. Further research is needed to fully understand these comorbidities in children.

Area of Science:

  • Dermatology
  • Pediatrics
  • Public Health

Background:

  • Pediatric psoriasis is a chronic inflammatory skin condition with significant long-term health implications.
  • Existing research primarily focuses on metabolic syndrome comorbidities, leaving other associated conditions understudied in children.
  • A comprehensive understanding of the full spectrum of comorbidities in pediatric psoriasis is lacking.

Purpose of the Study:

  • To provide an updated review of comorbidities associated with pediatric psoriasis, expanding beyond metabolic syndrome.
  • To elucidate the diverse range of health conditions linked to pediatric psoriasis in children.
  • To identify current knowledge gaps and highlight emerging research in pediatric psoriasis comorbidities.

Main Methods:

  • Literature review of existing studies on pediatric psoriasis and its associated comorbidities.
  • Analysis of current research trends and identification of under-explored areas.
  • Synthesis of findings to present a holistic view of the condition's impact.

Main Results:

  • Pediatric psoriasis is associated with a wide array of comorbidities beyond metabolic syndrome.
  • Emerging research indicates connections to various other chronic health conditions.
  • Significant gaps in knowledge persist regarding the full scope and impact of these comorbidities.

Conclusions:

  • A holistic clinical management approach is essential for pediatric psoriasis patients.
  • Further research is crucial to comprehensively understand the relationships between pediatric psoriasis and associated health outcomes.
  • Addressing knowledge gaps will improve long-term health management for affected children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
187